STOCKHOLDERS' EQUITY (Details Textual)

v2.4.0.6

STOCKHOLDERS' EQUITY (Details Textual) (USD $)	1 Months Ended		3 Months Ended				12 Months Ended										3 Months Ended					3 Months Ended	12 Months Ended		3 Months Ended	12 Months Ended		12 Months Ended		12 Months Ended		12 Months Ended		3 Months Ended	12 Months Ended	3 Months Ended			3 Months Ended			3 Months Ended			3 Months Ended			3 Months Ended		1 Months Ended		3 Months Ended				3 Months Ended		3 Months Ended												3 Months Ended			12 Months Ended			12 Months Ended
	Nov. 17, 2011	Mar. 31, 2010	Dec. 31, 2012	Feb. 29, 2012	Dec. 31, 2011	Mar. 31, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2010	Sep. 30, 2010	Sep. 30, 2006	Apr. 02, 2012	Mar. 22, 2012	Jun. 03, 2011	Apr. 30, 2011	Aug. 03, 2006	Dec. 31, 2012 Forfeiture and Exchange Agreements [Member]	Dec. 31, 2012 Plan 2012 [Member]	Dec. 31, 2011 Plan 2012 [Member]	Dec. 31, 2012 Plan 2006 [Member]	Mar. 03, 2010 Plan 2006 [Member]	Dec. 31, 2011 Unsecured Convertible Notes Payable [Member]	Sep. 30, 2012 Unsecured Convertible Notes Payable [Member]	Dec. 31, 2012 Unsecured Convertible Notes Payable [Member]	Dec. 31, 2011 Warrant One [Member]	Sep. 30, 2012 Warrant One [Member]	Sep. 30, 2011 Warrant One [Member]	Sep. 30, 2012 Warrant Two [Member]	Dec. 31, 2012 Warrant Two [Member]	Sep. 30, 2012 Warrant Three [Member]	Dec. 31, 2012 Warrant Three [Member]	Sep. 30, 2012 Warrant Four [Member]	Sep. 30, 2012 Warrant Five [Member]	Dec. 31, 2012 Common Stock [Member]	Sep. 30, 2012 Common Stock [Member]	Dec. 31, 2012 Minimum [Member]	Dec. 31, 2011 Minimum [Member]	Dec. 31, 2012 Minimum [Member] Plan 2012 [Member]	Dec. 31, 2012 Maximum [Member]	Dec. 31, 2011 Maximum [Member]	Dec. 31, 2012 Maximum [Member] Plan 2012 [Member]	Dec. 31, 2012 Sail Venture Partners [Member] Warrant Three [Member] Secured Convertible Subordinated Notes Payable [Member]	Dec. 31, 2012 Investor [Member] Warrant Three [Member]	Dec. 31, 2011 Investor [Member] Warrant Three [Member]	Dec. 31, 2012 Investor One [Member] Warrant One [Member]	Dec. 31, 2011 Investor Two [Member] Warrant One [Member]	Dec. 31, 2012 Investor Two [Member] Warrant One [Member]	Dec. 31, 2012 Investor Two [Member] Warrant Two [Member]	Dec. 31, 2011 Investor Two [Member] Warrant Two [Member]	Mar. 31, 2011 Management [Member]	Mar. 31, 2010 Management [Member]	Dec. 31, 2012 Director [Member] Warrant One [Member]	Dec. 31, 2011 Director [Member] Warrant One [Member]	Dec. 31, 2012 Director One [Member]	Mar. 22, 2012 Director One [Member]	Dec. 31, 2012 Director Two [Member]	Mar. 22, 2012 Director Two [Member]	Dec. 31, 2012 George Carpenter [Member] Forfeiture and Exchange Agreements [Member]	Dec. 31, 2012 George Carpenter [Member] Plan 2012 [Member]	Dec. 31, 2012 Paul Buck [Member] Forfeiture and Exchange Agreements [Member]	Dec. 31, 2012 Paul Buck [Member] Plan 2012 [Member]	Dec. 31, 2012 Michael Darkoch [Member] Forfeiture and Exchange Agreements [Member]	Dec. 31, 2012 Michael Darkoch [Member] Plan 2012 [Member]	Dec. 31, 2011 Michael Darkoch [Member] Plan 2012 [Member]	Dec. 31, 2012 Three Existing and Four New Board [Member] Plan 2012 [Member]	Dec. 31, 2012 Five Former Directors [Member] Plan 2012 [Member]	Dec. 31, 2011 CNS California [Member]	Dec. 31, 2012 CNS California [Member]	Dec. 31, 2012 Colorado CNS Response [Member]	Dec. 31, 2012 Neuro-Therapy Clinic Inc [Member]	Dec. 31, 2012 Affiliated Entity [Member] Warrant One [Member]	Mar. 22, 2012 Affiliated Entity [Member] Warrant One [Member]	Sep. 30, 2010 Affiliated Entity [Member] Warrant One [Member] Unsecured Convertible Notes Payable [Member]	Dec. 31, 2012 Affiliated Entity [Member] Warrant One [Member] Unsecured Convertible Notes Payable [Member]	Mar. 22, 2012 Affiliated Entity [Member] Warrant One [Member] Unsecured Convertible Notes Payable [Member]	Dec. 31, 2011 Affiliated Entity [Member] Warrant Three [Member]
Common stock, shares authorized (in shares)			100,000,000				100,000,000																													1,000,000			10,000																													80,000,000	1,000,000	10,000
Common stock, par value (in dollars per share)			$ 0.001				$ 0.001
Common stock, shares issued (in shares)			2,079,965				1,914,175
Common stock, shares outstanding (in shares)			2,079,965				1,914,175
Preferred Stock, Shares Authorized			20,000,000																																																																	20,000,000
Stock issued for officers' salaries (in shares)																																		165,790
Shares issued for officers' salaries			$ 7,900																															$ 200			$ 44,000			$ 0
Common Stock, Capital Shares Reserved for Future Issuance		666,667										750,000,000	333,334			333,334					333,334
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee		133,333									100,000
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms			The option price for each share of stock subject to an option shall be (i) no less than the fair market value of a share of stock on the date the option is granted, if the option is an ISO, or (ii) no less than 85% of the fair market value of the stock on the date the option is granted, if the option is a NSO; provided, however, if the option is an ISO granted to an eligible employee who is a 10% shareholder, the option price for each share of stock subject to such ISO shall be no less than 110% of the fair market value of a share of stock on the date such ISO is granted. Stock options have a maximum term of ten years from the date of grant, except for ISOs granted to an eligible employee who is a 10% shareholder, in which case the maximum term is five years from the date of grant. ISOs may be granted only to eligible employees.
Debt Conversion, Converted Instrument, Warrants or Options Issued			67,170															696,673	138,897							613,782		31,112		696,673		5,334	15,167									520,666			60,001	700,000		233,335				26,667	250,002			233,335			16,667											30,000	13,334					83,334
Notes Payable, Related Parties			80,000		80,000		2,222,220								50,000			650,000													65,000												80,000		180,000		70,000		250,000				80,000																		40,000			90,000
Number of Shares, Granted			5,395,000																						439,689																									15,834	288,334
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value						$ 14.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number													42,670	439,689																																									8,334		8,334															8,334			8,334
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price													$ 3
Number of Shares, Exercised			0															5,437,670		70,825
Number of Shares, Outstanding at December 31, 2011			5,939,594				546,746													501,924				12,152					504,076												28,648
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number			6,132
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit					$ 3.00			$ 3																	$ 3.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit					$ 36.00			$ 32.70																	$ 36.00
Stock Issued During Period, Shares Warrants Surrendered In Lieu Of Cash					539
Warrants Outstanding Exercise Price			$ 9.90																																	$ 1			$ 9.90															$ 9.90
Warrants Outstanding Weighted Average Exercise Price			$ 4.35
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized			1,461,247
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			290,664															62,330		87,786									85,634
Conversion of promissory note																																			1,900				0
Conversion of promissory note (in shares)																																			40,000
Debt Conversion, Original Debt, Amount																																			50,000
Debt Instrument, Face Amount			9,612,000																					90,000			2,000,000																	750,000
Employee Compensation Terms Of Waiver			Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment of 50% of their salaries accrued from August 31, 2010 to September 30, 2012 .														Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment of 50% of their salaries accrued from August 31, 2010 to September 30, 2012 .
Employee Compensation Amount Of Waiver			56,250,000																																																							56,250		66,083		43,333
Shares Issued In Consideration For Waiver			56,250																																																							56,250		66,083		43,333
Employee Compensation Payment Terms			Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board of Directors to the extent the Board of Directors determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more.														Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board of Directors to the extent the Board of Directors determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more.
Single Financing Transaction Minimum Proceeds			5,000														5,000
Indemnity Conversion Price Per Share Maximum Limit			$ 0.04718														$ 0.04718																		$ 0.04718
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		305,000	333,334				305,000																			305,000												333,334			5,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,400,000																																																														250,000
Weighted Average Exercise Price, Granted			$ 0.04718																																																$ 16.50								$ 1,200,000		$ 1,400,000		$ 920,000		$ 0.04718	$ 25,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																																																																	36 months
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights			12.50																																																								12.50		12.50		12.50
Volume Of Shares Traded On Open Market			15,000
Trading Days			48 days																																	11 days			48 days
Per Share Value Of Shares Traded On Open Market			$ 0.83																																	$ 0.76			$ 0.83
Convertible Notes Payable			$ 2,000,000				$ 2,000,000																																$ 398,100																											$ 3,023,900
Debt Instrument, Convertible, Conversion Price																											$ 9.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 0.04718
Warants Exercise Price			$ 3
Warants Exercise Price As Adjusted			$ 1
Warrants To Purchase Common Stock	83,334			30,000	5,000		166,667	5,334	8,334	3,334												126,949	30,000													166,668	85,282		83,334																									6,667			446,675						8,334